US2023242924A1PendingUtilityA1
DNA Plasmids with Improved Expression
Est. expiryAug 29, 2032(~6.1 yrs left)· nominal 20-yr term from priority
Inventors:James A. Williams
A61K 39/00C12N 15/635C12N 15/70C12N 15/85C12N 2800/107C12N 2820/55A61K 48/00
80
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the production and use of covalently closed circular (ccc) recombinant plasmids, and more particulary to vector modifications that improve express of said DNA molecules in the target organism.
Claims
exact text as granted — not AI-modifiedClaimed is:
1 . An engineered bacterial cell comprising a Rep protein-dependent plasmid vector, a Rep protein gene that expresses a Rep protein, and a P L promoter that controls the expression of the Rep protein gene, and wherein the P L promoter comprises an OL1 mutation, wherein the OL1 mutation comprises either a single base substitution or a single base deletion that decreases or prevents repressor biding to OL1, and wherein the Rep protein-dependent plasmid vector comprises an R6K replication origin.
2 . The engineered bacterial cell of claim 1 , wherein the P L promoter comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO:10 and SEQ ID NO: 44.
3 . The engineered bacterial cell of claim 1 , wherein said Rep protein comprises an amino acid sequence of SEQ ID NO: 13, wherein the amino acid sequence comprises two mutations at amino acids 106 and 107 of SEQ ID NO:13.
4 . The engineered bacterial cell of claim 1 , wherein the sequences of the P L promoter comprising said OL1 mutation is selected from the group consisting of SEQ ID NO: 11 and SEQ ID NO: 12.
5 . The engineered bacterial cell of claim 1 , wherein the R6K replication origin comprises a nucleic acid sequence that possesses at least 90% sequence identity to SEQ ID NO: 1 or SEQ ID NO: 22.
6 . The engineered bacterial cell of claim 1 , wherein the Rep protein-dependent plasmid vector further comprises an RNA-OUT selectable marker.
7 . The engineered bacterial cell of claim 6 , wherein the RNA-OUT selectable marker comprises a nucleic acid sequence with at least 90% sequence identity to SEQ ID NO: 23 or SEQ ID NO: 36.Join the waitlist — get patent alerts
Track US2023242924A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.